rdf:type |
|
lifeskim:mentions |
umls-concept:C0007113,
umls-concept:C0015677,
umls-concept:C0205125,
umls-concept:C0205288,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0439806,
umls-concept:C0677850,
umls-concept:C0728940,
umls-concept:C0750502,
umls-concept:C1269955,
umls-concept:C1444775,
umls-concept:C1513155,
umls-concept:C1550291,
umls-concept:C2699153
|
pubmed:issue |
6
|
pubmed:dateCreated |
2003-9-30
|
pubmed:abstractText |
Although the standard of care for T3 and/or N1-2 rectal cancers includes adjuvant chemoradiation, it is unclear whether T3 N0 patients with limited microscopic perirectal fat invasion warrant further therapy. Our aim was to determine the prognostic significance of gross perirectal fat invasion, or depth of microscopic perirectal fat invasion, in T3 N0 rectal cancers following sharp mesorectal excision and no adjuvant therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0179-1958
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-92
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:12783251-Adipose Tissue,
pubmed-meshheading:12783251-Adult,
pubmed-meshheading:12783251-Aged,
pubmed-meshheading:12783251-Aged, 80 and over,
pubmed-meshheading:12783251-Databases, Factual,
pubmed-meshheading:12783251-Disease-Free Survival,
pubmed-meshheading:12783251-Humans,
pubmed-meshheading:12783251-Male,
pubmed-meshheading:12783251-Middle Aged,
pubmed-meshheading:12783251-Neoplasm Invasiveness,
pubmed-meshheading:12783251-Prognosis,
pubmed-meshheading:12783251-Prospective Studies,
pubmed-meshheading:12783251-Radiotherapy, Adjuvant,
pubmed-meshheading:12783251-Rectal Neoplasms,
pubmed-meshheading:12783251-Surgical Procedures, Operative
|
pubmed:year |
2003
|
pubmed:articleTitle |
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy.
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10021, New York, USA.
|
pubmed:publicationType |
Journal Article
|